TY - JOUR AU - Bulugahapitiya, U. AU - Siyambalapitiya, S. AU - Sithole, J. AU - Idris, I. PY - 2009 DA - 2009// TI - Is diabetes a coronary risk equivalent? Systematic review and meta-analysis JO - Diabet Med VL - 26 UR - https://doi.org/10.1111/j.1464-5491.2008.02640.x DO - 10.1111/j.1464-5491.2008.02640.x ID - Bulugahapitiya2009 ER - TY - JOUR AU - Antithrombotic Trialists, C. PY - 2002 DA - 2002// TI - Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients JO - BMJ VL - 324 UR - https://doi.org/10.1136/bmj.324.7329.71 DO - 10.1136/bmj.324.7329.71 ID - Antithrombotic Trialists2002 ER - TY - JOUR AU - Antithrombotic Trialists, C. AU - Baigent, C. AU - Blackwell, L. AU - Collins, R. AU - Emberson, J. AU - Godwin, J. AU - Peto, R. AU - Buring, J. AU - Hennekens, C. AU - Kearney, P. PY - 2009 DA - 2009// TI - Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60503-1 DO - 10.1016/S0140-6736(09)60503-1 ID - Antithrombotic Trialists2009 ER - TY - JOUR AU - Butalia, S. AU - Leung, A. A. AU - Ghali, W. A. AU - Rabi, D. M. PY - 2011 DA - 2011// TI - Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis JO - Cardiovasc Diabetol VL - 10 UR - https://doi.org/10.1186/1475-2840-10-25 DO - 10.1186/1475-2840-10-25 ID - Butalia2011 ER - TY - JOUR AU - Pignone, M. AU - Alberts, M. J. AU - Colwell, J. A. AU - Cushman, M. AU - Inzucchi, S. E. AU - Mukherjee, D. AU - Rosenson, R. S. AU - Williams, C. D. AU - Wilson, P. W. AU - Kirkman, M. S. PY - 2010 DA - 2010// TI - Aspirin for primary prevention of cardiovascular events in people with diabetes JO - J Am Coll Cardiol VL - 55 UR - https://doi.org/10.1016/j.jacc.2010.04.003 DO - 10.1016/j.jacc.2010.04.003 ID - Pignone2010 ER - TY - JOUR AU - Berardis, G. AU - Sacco, M. AU - Strippoli, G. F. AU - Pellegrini, F. AU - Graziano, G. AU - Tognoni, G. AU - Nicolucci, A. PY - 2009 DA - 2009// TI - Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials JO - BMJ VL - 339 UR - https://doi.org/10.1136/bmj.b4531 DO - 10.1136/bmj.b4531 ID - Berardis2009 ER - TY - JOUR AU - Zhang, C. AU - Sun, A. AU - Zhang, P. AU - Wu, C. AU - Zhang, S. AU - Fu, M. AU - Wang, K. AU - Zou, Y. AU - Ge, J. PY - 2010 DA - 2010// TI - Aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis JO - Diabetes Res Clin Pract VL - 87 UR - https://doi.org/10.1016/j.diabres.2009.09.029 DO - 10.1016/j.diabres.2009.09.029 ID - Zhang2010 ER - TY - JOUR AU - Ryden, L. AU - Grant, P. J. AU - Anker, S. D. AU - Berne, C. AU - Cosentino, F. AU - Danchin, N. AU - Deaton, C. AU - Escaned, J. AU - Hammes, H. P. PY - 2013 DA - 2013// TI - ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD) JO - Eur Heart J VL - 34 UR - https://doi.org/10.1093/eurheartj/eht108 DO - 10.1093/eurheartj/eht108 ID - Ryden2013 ER - TY - JOUR AU - Kunutsor, S. K. AU - Seidu, S. AU - Khunti, K. PY - 2017 DA - 2017// TI - Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials JO - Diabet Med VL - 34 UR - https://doi.org/10.1111/dme.13133 DO - 10.1111/dme.13133 ID - Kunutsor2017 ER - TY - JOUR AU - Bowman, L. AU - Bowman, L. AU - Mafham, M. AU - Wallendszus, K. AU - Stevens, W. AU - Buck, G. AU - Barton, J. AU - Murphy, K. AU - Aung, T. AU - Haynes, R. PY - 2018 DA - 2018// TI - Effects of aspirin for primary prevention in persons with diabetes mellitus JO - N Engl J Med VL - 379 UR - https://doi.org/10.1056/NEJMoa1804988 DO - 10.1056/NEJMoa1804988 ID - Bowman2018 ER - TY - JOUR AU - Gaziano, J. M. AU - Brotons, C. AU - Coppolecchia, R. AU - Cricelli, C. AU - Darius, H. AU - Gorelick, P. B. AU - Howard, G. AU - Pearson, T. A. AU - Rothwell, P. M. AU - Ruilope, L. M. PY - 2018 DA - 2018// TI - Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial JO - Lancet VL - 392 UR - https://doi.org/10.1016/S0140-6736(18)31924-X DO - 10.1016/S0140-6736(18)31924-X ID - Gaziano2018 ER - TY - JOUR AU - McNeil, J. J. AU - Wolfe, R. AU - Woods, R. L. AU - Tonkin, A. M. AU - Donnan, G. A. AU - Nelson, M. R. AU - Reid, C. M. AU - Lockery, J. E. AU - Kirpach, B. AU - Storey, E. PY - 2018 DA - 2018// TI - Effect of aspirin on cardiovascular events and bleeding in the healthy elderly JO - N Engl J Med VL - 379 UR - https://doi.org/10.1056/NEJMoa1805819 DO - 10.1056/NEJMoa1805819 ID - McNeil2018 ER - TY - JOUR PY - 2015 DA - 2015// TI - Standards of medical care in diabetes–2015: summary of revisions JO - Diabetes Care VL - 38 ID - ref13 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000097 DO - 10.1371/journal.pmed.1000097 ID - Moher2009 ER - TY - JOUR AU - Stewart, L. A. AU - Clarke, M. AU - Rovers, M. AU - Riley, R. D. AU - Simmonds, M. AU - Stewart, G. AU - Tierney, J. F. PY - 2015 DA - 2015// TI - Group P-ID: preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement JO - JAMA VL - 313 UR - https://doi.org/10.1001/jama.2015.3656 DO - 10.1001/jama.2015.3656 ID - Stewart2015 ER - TY - STD TI - Cochrane Collaboration Individual Patient Data Meta-analysis Methods Group. FAQs (Frequently Asked Questions) on IPD meta-analysis. http://www.ctu.mrc.ac.uk/cochrane/ipdmg/faq.asp#faq26. UR - http://www.ctu.mrc.ac.uk/cochrane/ipdmg/faq.asp#faq26 ID - ref16 ER - TY - JOUR AU - Riley, R. D. AU - Lambert, P. C. AU - Abo-Zaid, G. PY - 2010 DA - 2010// TI - Meta-analysis of individual participant data: rationale, conduct, and reporting JO - BMJ VL - 340 UR - https://doi.org/10.1136/bmj.c221 DO - 10.1136/bmj.c221 ID - Riley2010 ER - TY - JOUR AU - Higgins, J. P. AU - Altman, D. G. AU - Gotzsche, P. C. AU - Juni, P. AU - Moher, D. AU - Oxman, A. D. AU - Savovic, J. AU - Schulz, K. F. AU - Weeks, L. AU - Sterne, J. A. PY - 2011 DA - 2011// TI - The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials JO - BMJ VL - 343 UR - https://doi.org/10.1136/bmj.d5928 DO - 10.1136/bmj.d5928 ID - Higgins2011 ER - TY - JOUR AU - Cornfield, J. PY - 1951 DA - 1951// TI - A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix JO - J Natl Cancer Inst VL - 11 ID - Cornfield1951 ER - TY - JOUR AU - Higgins, J. P. AU - Thompson, S. G. AU - Deeks, J. J. AU - Altman, D. G. PY - 2003 DA - 2003// TI - Measuring inconsistency in meta-analyses JO - BMJ VL - 327 UR - https://doi.org/10.1136/bmj.327.7414.557 DO - 10.1136/bmj.327.7414.557 ID - Higgins2003 ER - TY - JOUR AU - Egger, M. AU - Davey Smith, G. AU - Schneider, M. AU - Minder, C. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - BMJ VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - JOUR AU - Peto, R. AU - Gray, R. AU - Collins, R. AU - Wheatley, K. AU - Hennekens, C. AU - Jamrozik, K. AU - Warlow, C. AU - Hafner, B. AU - Thompson, E. AU - Norton, S. PY - 1988 DA - 1988// TI - Randomised trial of prophylactic daily aspirin in British male doctors JO - Br Med J (Clin Res Ed) VL - 296 UR - https://doi.org/10.1136/bmj.296.6618.313 DO - 10.1136/bmj.296.6618.313 ID - Peto1988 ER - TY - JOUR PY - 1989 DA - 1989// TI - Final report on the aspirin component of the ongoing Physicians’ Health Study. Steering Committee of the Physicians’ Health Study Research Group JO - N Engl J Med VL - 321 UR - https://doi.org/10.1056/NEJM198907203210301 DO - 10.1056/NEJM198907203210301 ID - ref23 ER - TY - JOUR AU - Kassoff, A. AU - Buzney, S. M. AU - McMeel, J. W. AU - Weiter, J. J. AU - Doyle, G. J. AU - Immerman, R. L. AU - Friedman, G. R. AU - Klein, M. L. AU - Dreyer, R. AU - Chenoweth, R. AU - Handelman, I. PY - 1992 DA - 1992// TI - Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early treatment diabetic retinopathy study report 14, ETDRS Investigators JO - JAMA VL - 268 UR - https://doi.org/10.1001/jama.1992.03490100090033 DO - 10.1001/jama.1992.03490100090033 ID - Kassoff1992 ER - TY - JOUR PY - 1998 DA - 1998// TI - Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk JO - Lancet VL - 351 UR - https://doi.org/10.1016/S0140-6736(97)11475-1 DO - 10.1016/S0140-6736(97)11475-1 ID - ref25 ER - TY - JOUR AU - Hansson, L. AU - Zanchetti, A. AU - Carruthers, S. G. AU - Dahlof, B. AU - Elmfeldt, D. AU - Julius, S. AU - Menard, J. AU - Rahn, K. H. AU - Wedel, H. AU - Westerling, S. PY - 1998 DA - 1998// TI - Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial, HOT Study Group JO - Lancet VL - 351 UR - https://doi.org/10.1016/S0140-6736(98)04311-6 DO - 10.1016/S0140-6736(98)04311-6 ID - Hansson1998 ER - TY - JOUR AU - Sacco, M. AU - Pellegrini, F. AU - Roncaglioni, M. C. AU - Avanzini, F. AU - Tognoni, G. AU - Nicolucci, A. PY - 2003 DA - 2003// TI - Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.12.3264 DO - 10.2337/diacare.26.12.3264 ID - Sacco2003 ER - TY - JOUR AU - Ridker, P. M. AU - Cook, N. R. AU - Lee, I. M. AU - Gordon, D. AU - Gaziano, J. M. AU - Manson, J. E. AU - Hennekens, C. H. AU - Buring, J. E. PY - 2005 DA - 2005// TI - A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa050613 DO - 10.1056/NEJMoa050613 ID - Ridker2005 ER - TY - JOUR AU - Belch, J. AU - MacCuish, A. AU - Campbell, I. AU - Cobbe, S. AU - Taylor, R. AU - Prescott, R. AU - Lee, R. AU - Bancroft, J. AU - MacEwan, S. AU - Shepherd, J. PY - 2008 DA - 2008// TI - The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease JO - BMJ VL - 337 UR - https://doi.org/10.1136/bmj.a1840 DO - 10.1136/bmj.a1840 ID - Belch2008 ER - TY - JOUR AU - Ogawa, H. AU - Nakayama, M. AU - Morimoto, T. AU - Uemura, S. AU - Kanauchi, M. AU - Doi, N. AU - Jinnouchi, H. AU - Sugiyama, S. AU - Saito, Y. PY - 2008 DA - 2008// TI - Japanese primary prevention of atherosclerosis with aspirin for diabetes. Trial I: low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial JO - JAMA. VL - 300 UR - https://doi.org/10.1001/jama.2008.623 DO - 10.1001/jama.2008.623 ID - Ogawa2008 ER - TY - JOUR AU - Ikeda, Y. AU - Shimada, K. AU - Teramoto, T. AU - Uchiyama, S. AU - Yamazaki, T. AU - Oikawa, S. AU - Sugawara, M. AU - Ando, K. AU - Murata, M. AU - Yokoyama, K. PY - 2014 DA - 2014// TI - Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial JO - JAMA VL - 312 UR - https://doi.org/10.1001/jama.2014.15690 DO - 10.1001/jama.2014.15690 ID - Ikeda2014 ER - TY - JOUR AU - Larsen, S. B. AU - Grove, E. L. AU - Neergaard-Petersen, S. AU - Wurtz, M. AU - Hvas, A. M. AU - Kristensen, S. D. PY - 2015 DA - 2015// TI - Determinants of reduced antiplatelet effect of aspirin in patients with stable coronary artery disease JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0126767 DO - 10.1371/journal.pone.0126767 ID - Larsen2015 ER - TY - JOUR AU - Li, W. J. AU - Zhang, H. Y. AU - Miao, C. L. AU - Tang, R. B. AU - Du, X. AU - Shi, J. H. AU - Ma, C. S. PY - 2011 DA - 2011// TI - Cigarette smoking inhibits the anti-platelet activity of aspirin in patients with coronary heart disease JO - Chin Med J (Engl) VL - 124 ID - Li2011 ER - TY - JOUR AU - Snoep, J. D. AU - Hovens, M. M. AU - Eikenboom, J. C. AU - Bom, J. G. AU - Huisman, M. V. PY - 2007 DA - 2007// TI - Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis JO - Arch Intern Med VL - 167 UR - https://doi.org/10.1001/archinte.167.15.1593 DO - 10.1001/archinte.167.15.1593 ID - Snoep2007 ER - TY - JOUR AU - Krasopoulos, G. AU - Brister, S. J. AU - Beattie, W. S. AU - Buchanan, M. R. PY - 2008 DA - 2008// TI - Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis JO - BMJ VL - 336 UR - https://doi.org/10.1136/bmj.39430.529549.BE DO - 10.1136/bmj.39430.529549.BE ID - Krasopoulos2008 ER - TY - JOUR AU - Zheng, S. L. AU - Roddick, A. J. PY - 2019 DA - 2019// TI - Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis JO - JAMA VL - 321 UR - https://doi.org/10.1001/jama.2018.20578 DO - 10.1001/jama.2018.20578 ID - Zheng2019 ER - TY - JOUR AU - Fortuni, F. AU - Crimi, G. AU - Gritti, V. AU - Mirizzi, A. M. AU - Leonardi, S. AU - Ferrari, G. M. PY - 2019 DA - 2019// TI - Primum non nocere: an updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes JO - Eur J Prev Cardiol UR - https://doi.org/10.1177/2047487319826439 DO - 10.1177/2047487319826439 ID - Fortuni2019 ER - TY - JOUR AU - Berger, J. S. AU - Brown, D. L. AU - Becker, R. C. PY - 2008 DA - 2008// TI - Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis JO - Am J Med VL - 121 UR - https://doi.org/10.1016/j.amjmed.2007.10.002 DO - 10.1016/j.amjmed.2007.10.002 ID - Berger2008 ER - TY - JOUR AU - Derry, S. AU - Loke, Y. K. PY - 2000 DA - 2000// TI - Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis JO - BMJ VL - 321 UR - https://doi.org/10.1136/bmj.321.7270.1183 DO - 10.1136/bmj.321.7270.1183 ID - Derry2000 ER - TY - JOUR AU - Patrono, C. AU - Garcia Rodriguez, L. A. AU - Landolfi, R. AU - Baigent, C. PY - 2005 DA - 2005// TI - Low-dose aspirin for the prevention of atherothrombosis JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMra052717 DO - 10.1056/NEJMra052717 ID - Patrono2005 ER - TY - JOUR AU - Hernandez-Diaz, S. AU - Garcia Rodriguez, L. A. PY - 2006 DA - 2006// TI - Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications JO - BMC Med VL - 4 UR - https://doi.org/10.1186/1741-7015-4-22 DO - 10.1186/1741-7015-4-22 ID - Hernandez-Diaz2006 ER - TY - JOUR AU - Lippi, G. AU - Danese, E. AU - Favaloro, E. J. PY - 2019 DA - 2019// TI - Harms and benefits of using aspirin for primary prevention of cardiovascular disease: a narrative overview JO - Semin Thromb Hemost VL - 45 UR - https://doi.org/10.1055/s-0038-1675380 DO - 10.1055/s-0038-1675380 ID - Lippi2019 ER - TY - JOUR AU - Yerman, T. AU - Gan, W. Q. AU - Sin, D. D. PY - 2007 DA - 2007// TI - The influence of gender on the effects of aspirin in preventing myocardial infarction JO - BMC Med VL - 5 UR - https://doi.org/10.1186/1741-7015-5-29 DO - 10.1186/1741-7015-5-29 ID - Yerman2007 ER - TY - JOUR AU - Gum, P. A. AU - Kottke-Marchant, K. AU - Poggio, E. D. AU - Gurm, H. AU - Welsh, P. A. AU - Brooks, L. AU - Sapp, S. K. AU - Topol, E. J. PY - 2001 DA - 2001// TI - Profile and prevalence of aspirin resistance in patients with cardiovascular disease JO - Am J Cardiol VL - 88 UR - https://doi.org/10.1016/S0002-9149(01)01631-9 DO - 10.1016/S0002-9149(01)01631-9 ID - Gum2001 ER - TY - JOUR AU - Russo, I. AU - Penna, C. AU - Musso, T. AU - Popara, J. AU - Alloatti, G. AU - Cavalot, F. AU - Pagliaro, P. PY - 2017 DA - 2017// TI - Platelets, diabetes and myocardial ischemia/reperfusion injury JO - Cardiovasc Diabetol VL - 16 UR - https://doi.org/10.1186/s12933-017-0550-6 DO - 10.1186/s12933-017-0550-6 ID - Russo2017 ER - TY - JOUR AU - Leggio, M. AU - Bendini, M. G. AU - Caldarone, E. AU - Lombardi, M. AU - Severi, P. AU - D’Emidio, S. AU - Stavri, D. C. AU - Armeni, M. AU - Bravi, V. AU - Mazza, A. PY - 2018 DA - 2018// TI - Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: benefit or risk? JO - Diabetes Metab VL - 44 UR - https://doi.org/10.1016/j.diabet.2017.11.002 DO - 10.1016/j.diabet.2017.11.002 ID - Leggio2018 ER -